News Release: MGW Applies For Dealer's License CALGARY, Alberta, March 15, 2018 -- Maple Leaf Green World Inc. (“Maple Leaf” or the “Company”) (TSXV:MGW) (OTCQB:MGWFF) is pleased to announce that it has engaged Cannabis Compliance Inc. (“CCI”) to apply to the Office of Controlled Substances within Health Canada for a Dealer’s License pursuant to the Controlled Drugs and Substances Act. A Dealer’s Licence would allow the Company to import and export fresh and dried marijuana, cannabis oils, and concentrates; formulate research and development of cannabis products in various dosage forms; and conduct analytical testing. The Dealer’s Licence would also compliment Maple Leaf’s application for an Access to Cannabis for Medical Purposes Regulations (“ACMPR”) licence. The Company’s application to Health Canada for the ACMPR licence has progressed to the review stage which coincides with the Company’s facility located in Telkwa, British Columbia currently under construction. With both a Dealer’s Licence and ACMPR licence, the Company will be able to cultivate, extract, test, import, export, and produce medical cannabis products, including concentrated oil and resin products, internationally. According to CCI, the application process to obtain a Dealer’s Licence from the Office of Controlled Substances will take approximately 6 to 9 months.